[B018] 药物基本信息

get
https://connect.zhihuiya.com/synapse/drug/detail
在体验中心中试用

获取药物基本信息，包括名称，靶点，适应症，在研机构等

请求参数

此 API 接口支持的参数列表

名称类型示例描述
drug_id
必填
string11d208e0c26a4345946d95f92d9fcaf0
药物id，通过药物搜索接口或药物自动补全接口获取

响应结构

API 响应数据的结构说明

字段名类型示例描述
data
object-
响应数据
target
array[ { "target_id": "928facc8122849baa0dc00759cff0380", "short_name": [ { "lang": "EN", "name": "KRAS G12C" } ], "display_name": [ { "lang": "EN", "name": "GTPase KRas G12C" }, { "lang": "CN", "name": "KRAS G12C突变" } ] } ]
靶点详情
hgnc_id
array[ "HGNC:12680" ]
HGNC ID列表
mesh_id
array[ "7422" ]
MESH ID列表
target_id
string1c2067e5ab054a8995f73efcfcf56207
靶点ID
short_name
array[ { "lang": "EN", "name": "VEGF" } ]
靶点简称，引用“CommonName”
lang
stringEN
语言
name
stringRanibizumab (Genentech)
药物、靶点、机构、适应症、国家/地区、字典、作用机制 名称
gene_symbol
array[ { "lang": "EN", "name": "VEGFA" } ]
靶点
display_name
array[ { "lang": "EN", "name": "Vascular endothelial growth factor" }, { "lang": "CN", "name": "血管内皮生长因子" } ]
靶点全称，引用“CommonName”
disease
array[ { "disease_id": "a0304a462da04e7cb03e3f2c5625544e", "display_name": [ { "lang": "EN", "name": "Advanced Lung Non-Small Cell Carcinoma" }, { "lang": "CN", "name": "晚期非小细胞肺癌" } ] } ]
适应症详情
umls
array[ "C0021368", "C0021364" ]
UMLS ID列表
disease_id
string06a9082fe1ec4c97bea31d888b9cfdce
适应症ID
display_name
array[ { "lang": "EN", "name": "Uveitic Macular Edema" }, { "lang": "CN", "name": "葡萄膜炎黄斑水肿" } ]
适应症名称，引用“CommonName”
drug_id
string2838b95ade834c96b17ac8bcd2b68c27
药物ID
dev_code
arrayPlease check the form: DrugDevCodeResponseDto
研发编码
code
stringJP 1366
编码
name
stringJP 1366
名称
status
stringACTIVE
状态
sequence
array[ { "chain_type": [ "L" ], "sequence_text": "DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC", "sequence_number": 43254 } ]
序列
chain_type
array[ "L" ]
链类型
sequence_text
stringDILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
序列
sequence_number
integer<int64>43254
序列号
atc_codes
array[ "L01XE44" ]
ATC码
drug_name
array[ { "lang": "CN", "name": "索托拉西布" }, { "lang": "EN", "name": "Sotorasib" }, { "lang": "JP", "name": "ソトラシブ" } ]
药物名称
drug_type
array[ { "display_name": [ { "lang": "EN", "name": "Small molecule drug" }, { "lang": "CN", "name": "小分子化药" } ], "normalized_id": "1151dbc710f64a85923dc05d4a5a0ba9" } ]
药物类型详情
display_name
array[ { "lang": "EN", "name": "Autologous CAR-T" }, { "lang": "CN", "name": "自体CAR-T" } ]
字典名称
normalized_id
string2fbfdb3e92d942c48cbb0adb79f23526
字典ID
structure
array[ { "base64": "data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASwAAAEsCAYAAAB5fY51AAAAIGNIUk0AAHomAACAhAAA+gAAAIDoAAB1MAAA6mAAADqYAAAXcJy6UTwAAAAEZ0FNQQ", "formula": "C30H30F2N6O3", "inchi_key": "NXQKSXLFSAEQCZ-SFHVURJKSA-N" } ]
结构式
base64
stringdata:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASwAAAEsCAYAAAB5fY51AAAAIGNIUk0AAHomAACAhAAA+gAAAIDoAAB1MAAA6mAAADqYAAAXcJy6UTwAAAAEZ0FNQQ
序列图base64编码
formula
stringC30H30F2N6O3
分子式
inchi_key
stringNXQKSXLFSAEQCZ-SFHVURJKSA-N
inChiKey
canonical_smiles
stringCNC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O
canonicalSmiles
isometric_smiles
stringCNC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O
isometricSmiles
alias_name
array[ { "lang": "CN", "name": "索托雷塞" }, { "lang": "CN", "name": "索拖拉西布" } ]
别名
exist_deal
booleantrue
是否存在交易
trade_name
array[ { "name": "Lumakras" }, { "name": "Lumykras" }, { "name": "ルマケラス" } ]
商品名
generic_name
array[ { "lang": "CN", "name": "索托拉西布" }, { "lang": "EN", "name": "Sotorasib" }, { "lang": "JP", "name": "ソトラシブ" } ]
通用名
patent_mining
boolean-
专利挖掘
milestone_tags
array[ { "date": "2023-05-01", "name": "First Phase 2 Clinical" }, { "date": "2023-06-15", "name": "First Phase 3 Clinical" } ]
研发里程碑标签
date
integer<int64>1409788800000
里程碑日期
name
array[ { "lang": "EN", "name": "FDA Approval" }, { "lang": "CN", "name": "FDA批准" } ]
里程碑名称
approval_country
array[ { "country_id": "0dc5d896-7408-3c87-84c0-22e3d9b784be", "alpha2_code": "US", "display_name": [ { "lang": "EN", "name": "United States" }, { "lang": "CN", "name": "美国" } ] } ]
获批国家/地区
country_id
string676de5ba-893a-36bb-8683-c93306aaf769
国家地区ID
alpha2_code
stringUS
国家编码
display_name
array[ { "lang": "EN", "name": "United States" }, { "lang": "CN", "name": "美国" } ]
国家地区名称
mechanism_action
array[ { "short_name": [ { "lang": "EN", "name": "KRAS G12C inhibitors" }, { "lang": "CN", "name": "KRAS G12C抑制剂" } ], "display_name": [ { "lang": "EN", "name": "GTPase KRas G12C inhibitors" }, { "lang": "CN", "name": "KRAS G12C突变抑制剂" } ], "mechanism_id": "27c0848a265e4332836e10d0e8202b4c" } ]
作用机制详情
short_name
array[ { "lang": "EN", "name": "KRAS G12C inhibitors" }, { "lang": "CN", "name": "KRAS G12C抑制剂" } ]
作用机制简称
display_name
array[ { "lang": "EN", "name": "GTPase KRas G12C inhibitors" }, { "lang": "CN", "name": "KRAS G12C突变抑制剂" } ]
作用机制 名称
mechanism_id
string27c0848a265e4332836e10d0e8202b4c
作用机制ID
research_disease
array[ { "disease_id": "a0304a462da04e7cb03e3f2c5625544e", "display_name": [ { "lang": "EN", "name": "Advanced Lung Non-Small Cell Carcinoma" }, { "lang": "CN", "name": "晚期非小细胞肺癌" } ] } ]
在研适应症详情
special_approval
array[ { "country": { "country_id": "5a365096-b2a6-31cb-acdf-1de1f5ab3abe", "alpha2_code": "CN", "display_name": [ { "lang": "EN", "name": "China" }, { "lang": "CN", "name": "中国" } ] }, "special_view": { "display_name": [ { "lang": "EN", "name": "Breakthrough Therapy" }, { "lang": "CN", "name": "突破性疗法" } ], "normalized_id": "c3c948340a7d40f3b7437081f5e8cb4e" } } ]
特殊审评
country
object{ "country_id": "5a365096-b2a6-31cb-acdf-1de1f5ab3abe", "alpha2_code": "CN", "display_name": [ { "lang": "EN", "name": "China" }, { "lang": "CN", "name": "中国" } ] }
国家地区
special_view
object{ "display_name": [ { "lang": "EN", "name": "Breakthrough Therapy" }, { "lang": "CN", "name": "突破性疗法" } ], "normalized_id": "c3c948340a7d40f3b7437081f5e8cb4e" }
特殊审批
therapeutic_area
array[ { "disease_id": "62eaee6d9ee44410b8aca59dfc7408e9", "display_name": [ { "lang": "EN", "name": "Neoplasms" }, { "lang": "CN", "name": "肿瘤" } ] } ]
治疗领域详情
deal_organization
array[ { "display_name": [ { "lang": "EN", "name": "Amgen, Inc." }, { "lang": "CN", "name": "安进股份有限公司" } ], "organization_id": "11ef8a9e8bf5ca80213a1183511cded3" } ]
权益机构详情
display_name
array[ { "lang": "EN", "name": "Roche Holding AG" }, { "lang": "CN", "name": "罗氏" } ]
机构名称，引用“CommonName”
organization_id
string87bfaf037f8e60c9e25595cd98bb27e4
机构ID
active_organization
array[ { "display_name": [ { "lang": "EN", "name": "Amgen, Inc." }, { "lang": "CN", "name": "安进股份有限公司" } ], "organization_id": "11ef8a9e8bf5ca80213a1183511cded3" } ]
在研机构详情
first_approval_date
integer<int64>1409788800000
首次获批日期
non_research_disease
array[ { "disease_id": "a1ddbb69fd3e46b6980bd4e1f1e64a45", "display_name": [ { "lang": "EN", "name": "Advanced Pancreatic Adenocarcinoma" }, { "lang": "CN", "name": "晚期胰腺腺癌" } ] } ]
非在研适应症详情
highest_dev_status_cn
object{ "display_name": [ { "lang": "EN", "name": "Phase 3" }, { "lang": "CN", "name": "临床3期" } ], "normalized_id": "f835774c48404593b64ef05369eb8eba" }
最高研发状态-中国
inactive_organization
array[ { "display_name": [ { "lang": "EN", "name": "Amgen, Inc." }, { "lang": "CN", "name": "安进股份有限公司" } ], "organization_id": "11ef8a9e8bf5ca80213a1183511cded3" } ]
非在研机构详情
first_approval_date_cn
integer<int64>1532044800000
首次获批日期（中国）
first_approved_country
array[ { "country_id": "52d1b118-b540-37ba-9cb2-f5aff686bb10", "alpha2_code": "KR", "display_name": [ { "lang": "EN", "name": "South Korea" }, { "lang": "CN", "name": "韩国" } ] } ]
首次获批国家/地区
first_approved_disease
array[ { "disease_id": "b3d498b086894c13bf5ac981a350af82", "display_name": [ { "lang": "EN", "name": "KRAS G12C mutant Non-small Cell Lung Cancer" }, { "lang": "CN", "name": "KRAS G12C突变非小细胞肺癌" } ] } ]
首次获批适应症详情
originator_organization
array[ { "display_name": [ { "lang": "EN", "name": "Amgen, Inc." }, { "lang": "CN", "name": "安进股份有限公司" } ], "organization_id": "11ef8a9e8bf5ca80213a1183511cded3" } ]
原研机构详情
global_highest_dev_status
object{ "display_name": [ { "lang": "EN", "name": "Approved" }, { "lang": "CN", "name": "批准上市" } ], "normalized_id": "efd6215835394b07b046125e3175d3fe" }
最高研发状态
status
必填
booleanfalse
状态
error_msg
stringThe request parameter format is incorrect！
错误信息
error_code
必填
integer0
错误代码

成功响应示例

成功调用 API 的响应示例

JSON 
{
  "data": {
    "target": [
      {
        "hgnc_id": [
          "HGNC:12680"
        ],
        "mesh_id": [
          "7422"
        ],
        "target_id": "1c2067e5ab054a8995f73efcfcf56207",
        "short_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "gene_symbol": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "disease": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "drug_id": "2838b95ade834c96b17ac8bcd2b68c27",
    "dev_code": [
      {
        "code": "JP 1366",
        "name": "JP 1366",
        "status": "ACTIVE"
      }
    ],
    "sequence": [
      {
        "chain_type": [
          "L"
        ],
        "sequence_text": "DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC",
        "sequence_number": 43254
      }
    ],
    "atc_codes": [
      "L01XE44"
    ],
    "drug_name": [
      {
        "lang": "EN",
        "name": "Ranibizumab (Genentech)"
      }
    ],
    "drug_type": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
      }
    ],
    "structure": [
      {
        "base64": "data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASwAAAEsCAYAAAB5fY51AAAAIGNIUk0AAHomAACAhAAA+gAAAIDoAAB1MAAA6mAAADqYAAAXcJy6UTwAAAAEZ0FNQQ",
        "formula": "C30H30F2N6O3",
        "inchi_key": "NXQKSXLFSAEQCZ-SFHVURJKSA-N",
        "canonical_smiles": "CNC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O",
        "isometric_smiles": "CNC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O"
      }
    ],
    "alias_name": [
      {
        "lang": "EN",
        "name": "Ranibizumab (Genentech)"
      }
    ],
    "exist_deal": true,
    "trade_name": [
      {
        "lang": "EN",
        "name": "Ranibizumab (Genentech)"
      }
    ],
    "generic_name": [
      {
        "lang": "EN",
        "name": "Ranibizumab (Genentech)"
      }
    ],
    "patent_mining": false,
    "milestone_tags": [
      {
        "date": 1409788800000,
        "name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "approval_country": [
      {
        "country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
        "alpha2_code": "US",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "mechanism_action": [
      {
        "short_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "mechanism_id": "27c0848a265e4332836e10d0e8202b4c"
      }
    ],
    "research_disease": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "special_approval": [
      {
        "country": {
          "country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
          "alpha2_code": "US",
          "display_name": [
            {
              "lang": "EN",
              "name": "Ranibizumab (Genentech)"
            }
          ]
        },
        "special_view": {
          "display_name": [
            {
              "lang": "EN",
              "name": "Ranibizumab (Genentech)"
            }
          ],
          "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
        }
      }
    ],
    "therapeutic_area": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "deal_organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "active_organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "first_approval_date": 1409788800000,
    "non_research_disease": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "highest_dev_status_cn": {
      "display_name": [
        {
          "lang": "EN",
          "name": "Ranibizumab (Genentech)"
        }
      ],
      "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
    },
    "inactive_organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "first_approval_date_cn": 1532044800000,
    "first_approved_country": [
      {
        "country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
        "alpha2_code": "US",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "first_approved_disease": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "originator_organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "global_highest_dev_status": {
      "display_name": [
        {
          "lang": "EN",
          "name": "Ranibizumab (Genentech)"
        }
      ],
      "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
    }
  },
  "status": true,
  "error_code": 0
}

错误码

此接口可能返回的错误码列表

业务错误码

错误码描述
68300004请求参数异常!
68300005查询Api失败!
68300006解析基本存取错误!
68300007存在错误的请求!
68300008服务中断异常，请稍后再试!
68300010文件不符合上传规范!

平台错误码

错误码描述
67200000API整体限流错误!
67200001API整体限流错误！
67200002当前调用速率过快,超过当前配置限制QPS！
67200003申请token的key和secret传参不正确或者客户端已被禁用！
67200004请求的接口无权限请联系我们的支持人员！
67200005账户余额/调用次数不足！
67200006客户端超过开通有效期！
67200007当前调用超过当天配置使用额度！
67200008请检查query参数中必填的apikey是否传输！
67200009apikey与所传的bearerToken不匹配,请检查是否使用在有效期内的token！
67200012请求不合法！
67200100当前服务器状态正忙,请求响应超时！
67200101当前请求的Api不存在请检查请求Path！

HTTP 状态码

状态码描述
0请求成功
401Unauthorized
403Forbidden
404Not Found

性能指标

此接口的预期性能特征

正常响应时间

5000 ms

最大响应时间

10000 ms